Highlights |
FDA reviewers prefer tougher approval process for transvaginal mesh
Friday, 9 September 2011- Transvaginal mesh devices should not be approved for surgical repair of pelvic organ prolapse through the less-rigorous 510(k) process because of safety concerns, according to Food and Drug...
Edited by: JV
Dutch study: cranberries not as effective as antibiotics in women with UTI
Wednesday, 27 July 2011- Cranberry extract was not as effective as trimethoprim-sulfamethoxazole (TMP-SMX) in preventing urinary tract infections in women, according to a double-blind study conducted by Dutch researchers.
During...
Edited by: JV
Prolapse follow-up beyond five years: myth or reality?
Monday, 25 July 2011- A group of researchers conducted a study to examine the loss to follow-up (LTF) rate in level I/II evidence-based studies related to the surgical management of pelvic organ prolapse (POP). R. Ou and...
Edited by: JV
Surgically managing mesh-related complications after prior pelvic floor reconstructive surgery
Thursday, 14 July 2011- M. Tijdink and colleagues conducted a study to evaluate the complications and anatomical and functional outcomes of the surgical treatment of mesh-related complications. They published their findings...
Edited by: JV
Mesh is riskier but higher success rates for treating pelvic organ prolapse
Friday, 13 May 2011- For women with pelvic-organ prolapse, a transvaginal mesh kit improves treatment success rates compared with traditional colporrhaphy. However, the treatment comes at a cost of more surgical complications and...
Edited by: JV
